Okla. Stat. tit. 63, § 63-1-757.5: Promulgation of rules – Requirements for manufacturers

and distributors – Requirements for physicians.

A. The State Board of Pharmacy shall promulgate rules to create

a certification program to oversee and regulate the manufacture and

distribution of abortion-inducing drugs by manufacturers and

distributors licensed by the State Board of Pharmacy.

B. The State Board of Pharmacy shall establish the following

requirements for manufacturers and distributors of abortion-inducing

drugs, at a minimum:

1. Require completion of the certification process for

manufacturers and distributors as described in Section 6 of this

act;

2. Require that abortion-inducing drugs be transported and

provided in this state only by manufacturers or distributors

certified to do so under this program;

3. Notify manufacturers and distributors of physicians

certified under the Oklahoma Abortion-Inducing Drug Certification

Program;

4. Prohibit shipment of abortion-inducing drugs to physicians

who become de-certified from the Oklahoma Abortion-Inducing Drug

Certification Program;

5. Audit newly certified manufacturers and distributors within

ninety (90) calendar days after the manufacturer or distributor is

authorized, and annually thereafter, to ensure that all processes

and procedures are in place and functioning to support the

requirements of the Oklahoma Abortion-Inducing Drug Certification

Program;

6. If a manufacturer or distributor is found to be

noncompliant, immediately suspend manufacturer's or distributor's

certification until the manufacturer or distributor demonstrates

full compliance; and

7. Enforce compliance according to Section 12 of this act.

C. The State Board of Medical Licensure and Supervision and the

State Board of Osteopathic Examiners shall promulgate rules to

create a certification program to oversee and regulate the provision

of abortion-inducing drugs by physicians licensed by the respective

state licensing board. The drugs shall only be provided to patients

by fully licensed physicians certified to do so under this program

by their respective state licensing boards.

D. The State Board of Medical Licensure and Supervision and the

State Board of Osteopathic Examiners shall establish the following

requirements for physicians providing abortion-inducing drugs, at a

minimum:

1. Require completion of the certification process for

physicians as described in Section 7 of this act;

2. Audit newly certified physicians within ninety (90) calendar

days after the physician is authorized, and annually thereafter, to

ensure that all required processes and procedures are in place and

functioning to support the requirements of the Oklahoma Abortion-

Inducing Drug Certification Program;

3. If a physician is found to be noncompliant, immediately

suspend the physician's certification until such time that the

physician demonstrates full compliance;

4. Develop a reporting system as specified in Section 9 of this

act; and

5. Enforce compliance according to Section 12 of this act.